High-dose endomorphin-1 and endomorphin-2 both caused anti-analgesia (pain) in the brainstem, but through different mechanisms — endomorphin-1 via direct NMDA activation, endomorphin-2 via dynorphin release — different peptides, different pronociceptive pathways.
Key findingHigh-dose endomorphin-1 anti-analgesia in ventral PAG was mediated by direct NMDA receptor activation, while endomorphin-2 worked through dynorphin A
What the researchers found
High-dose endomorphin-1 anti-analgesia in ventral PAG was mediated by direct NMDA receptor activation, while endomorphin-2 worked through dynorphin A release → kappa/NMDA pathways — two endogenous mu-agonists producing pain through distinct mechanisms.
Why it matters
Relevant for opioid-peptides, pain.
How the study worked
animal-study study on opioid-peptides, pain.
What this study cannot tell us
See abstract.
How to read the evidence
preliminary evidence.
When this study was published
Published in 2005.
The bigger picture
Advances peptide/biomarker research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Differential mechanisms of antianalgesia induced by endomorphin-1 and endomorphin-2 in the ventral periaqueductal gray of the rat.
The Journal of pharmacology and experimental therapeutics, 312(3), 1257-65
Citation
Terashvili, Maia; Wu, Hsiang-En; Leitermann, Randy J; Sun, Han-Sen; Clithero, Andrew D; Tseng, Leon F. (2005). Differential mechanisms of antianalgesia induced by endomorphin-1 and endomorphin-2 in the ventral periaqueductal gray of the rat.. The Journal of pharmacology and experimental therapeutics, 312(3), 1257-65.